Volatile Trading Session: Market participants highlighted CRVO's sharp intraday swings following a significant run-up the previous session, with the stock opening near $3.34 and reaching highs above $7 before settling lower amid broader profit-taking.
Low Float Dynamics: Discussion centered on the ticker's tight float of approximately 5.84 million shares and its resilience above key PIPE levels, drawing attention from traders monitoring potential continuation or reversal patterns in the near term.
Market Sentiment Snapshot: Overall chatter reflected short-term caution after the pullback, with some observers noting ongoing interest in breakout setups despite the day's declines.
Note: This discussion summary was generated from an AI condensation of post data.
CervoMed Insider Trading Activity
CervoMed insiders have traded $CRVO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CRVO stock by insiders over the last 6 months:
- JOSHUA S BOGER purchased 955,414 shares for an estimated $2,999,999
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
CervoMed Hedge Fund Activity
We have seen 18 institutional investors add shares of CervoMed stock to their portfolio, and 25 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AWM INVESTMENT COMPANY, INC. removed 794,634 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,130,857
- MORGAN STANLEY added 265,398 shares (+55.9%) to their portfolio in Q1 2026, for an estimated $1,045,668
- MILLENNIUM MANAGEMENT LLC added 148,640 shares (+246.6%) to their portfolio in Q1 2026, for an estimated $585,641
- NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO removed 84,260 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $331,984
- RENAISSANCE TECHNOLOGIES LLC added 63,904 shares (+inf%) to their portfolio in Q1 2026, for an estimated $251,781
- CITADEL ADVISORS LLC removed 49,250 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $194,045
- PERIGON WEALTH MANAGEMENT, LLC removed 29,531 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $116,352
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
CervoMed Price Targets
Multiple analysts have issued price targets for $CRVO recently. We have seen 4 analysts offer price targets for $CRVO in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $25.0 on 04/23/2026
- Jason Kolbert from D. Boral Capital set a target price of $31.0 on 04/22/2026
- Daniil Gataulin from Chardan Capital set a target price of $21.0 on 03/18/2026
- Boobalan Pachaiyappan from Roth Capital set a target price of $11.0 on 03/18/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
